SEC 13F Intelligence

Farallon Capital Management, L.L.C. / ELV

Farallon Capital Management, L.L.C.’s Elevance Health Inc Formerly Position

Does Farallon Capital Management, L.L.C. own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 381.3K shares worth $166M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$166M
Q3 2023
Shares
381.3K
% of Portfolio
+0.71%
Quarters Held
20
position exited

Position History ELV

Reported value by quarter
Q4 ’18: $276MQ4 ’18Q1 ’19: $237MQ2 ’19: $296MQ3 ’19: $255MQ3 ’19Q4 ’19: $378MQ1 ’20: $284MQ2 ’20: $329MQ2 ’20Q3 ’20: $342MQ4 ’20: $409MQ1 ’21: $296MQ1 ’21Q2 ’21: $248MQ3 ’21: $319MQ4 ’21: $350MQ4 ’21Q1 ’22: $378MQ2 ’22: $399MQ3 ’22: $364MQ3 ’22Q4 ’22: $325MQ1 ’23: $310MQ2 ’23: $198MQ2 ’23Q3 ’23: $166Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023381.3K$166M+0.71%
Q2 2023445.3K$198M+1.10%
Q1 2023673.6K$310M+1.53%
Q4 2022634.3K$325M+2.13%
Q3 2022801.4K$364M+2.00%
Q2 2022826.5K$399M+2.25%
Q1 2022768.8K$378M+1.66%
Q4 2021755.1K$350M+1.81%
Q3 2021855.0K$319M+1.54%
Q2 2021650.0K$248M+1.02%
Q1 2021825.0K$296M+1.64%
Q4 20201.27M$409M+2.62%
Q3 20201.27M$342M+2.40%
Q2 20201.25M$329M+2.66%
Q1 20201.25M$284M+1.75%
Q4 20191.25M$378M+3.03%
Q3 20191.06M$255M+2.13%
Q2 20191.05M$296M+2.45%
Q1 2019825.0K$237M+1.90%
Q4 20181.05M$276M+2.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of ELV.